IE39283B1 - Tablet formulation - Google Patents
Tablet formulationInfo
- Publication number
- IE39283B1 IE39283B1 IE1097/74A IE109774A IE39283B1 IE 39283 B1 IE39283 B1 IE 39283B1 IE 1097/74 A IE1097/74 A IE 1097/74A IE 109774 A IE109774 A IE 109774A IE 39283 B1 IE39283 B1 IE 39283B1
- Authority
- IE
- Ireland
- Prior art keywords
- allopurinol
- agent
- starch
- tablet formulations
- disintegrating agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1460302 Allopurinol tablet formulations WELLCOME FOUNDATION Ltd 23 May 1974 [23 May 1973] 24628/73 Heading A5B Tablet formulations comprise from 80 to 98% w/w of allopurinol (4-hydroxy pyrazolo (3, 4-d) pyrimidine) having a particle size from 2 to 40Ám, from 1 to 19% w/w of a disintegrating agent and from 1 to 19% of a granulating agent. The disintegrating agent may be alginic acid, a sodium starch glycolate, a guar-based vegetable gum or calcium carboxymethyl cellulose and the granulating agent may be starch mucilage, a starch derivative, a cellulose derivative, polyvinylpyrrolidine or gelatin. The formulations are compressed on standard machinery to form tablets for use in treating gout and other hyperuricaemic conditions.
[GB1460302A]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2462873A GB1460302A (en) | 1973-05-23 | 1973-05-23 | Tablet formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
IE39283L IE39283L (en) | 1974-11-23 |
IE39283B1 true IE39283B1 (en) | 1978-09-13 |
Family
ID=10214700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE1097/74A IE39283B1 (en) | 1973-05-23 | 1974-05-22 | Tablet formulation |
Country Status (21)
Country | Link |
---|---|
JP (1) | JPS577128B2 (en) |
AT (1) | AT351167B (en) |
AU (1) | AU469472B2 (en) |
BE (1) | BE815409A (en) |
CA (1) | CA977279A (en) |
CY (1) | CY941A (en) |
DE (1) | DE2424950A1 (en) |
DK (1) | DK144261C (en) |
FI (1) | FI156674A (en) |
FR (1) | FR2230341B1 (en) |
GB (1) | GB1460302A (en) |
HK (1) | HK1378A (en) |
HU (1) | HU170656B (en) |
IE (1) | IE39283B1 (en) |
IL (1) | IL44877A (en) |
IT (1) | IT8048966A0 (en) |
KE (1) | KE2808A (en) |
MY (1) | MY7800181A (en) |
NL (1) | NL190436C (en) |
SE (1) | SE402525C (en) |
ZA (1) | ZA743318B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1533243A (en) * | 1975-02-13 | 1978-11-22 | Wellcome Found | Tablet formulation |
US4143129A (en) | 1975-10-11 | 1979-03-06 | Lilly Industries Limited | Cephalexin tablets |
US4115563A (en) * | 1977-03-14 | 1978-09-19 | Sterling Drug Inc. | Pharmaceutical steroid formulation |
GB1601833A (en) * | 1978-02-06 | 1981-11-04 | Wellcome Found | Antacid formulation |
DE3839825A1 (en) * | 1988-11-25 | 1990-06-13 | Henning Berlin Gmbh | SOLIDS DISPERSIONS CONTAIN OXIPURINOL AND / OR ITS ALKALI OR EARTH ALKALISALZE |
WO1996002234A1 (en) * | 1994-07-18 | 1996-02-01 | Luis Cipriano Carvajal Martin | Self-desintegrating compact granules used in galenic forms and containing active insoluble or hardly soluble principles |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB975850A (en) * | 1955-08-10 | 1964-11-18 | Wellcome Found | Xanthine oxidase inhibitors |
US3624205A (en) * | 1967-04-25 | 1971-11-30 | Burroughs Wellcome Co | Treatment of hyperuricemia in humans |
-
1973
- 1973-05-23 GB GB2462873A patent/GB1460302A/en not_active Expired
-
1974
- 1974-05-22 ZA ZA00743318A patent/ZA743318B/en unknown
- 1974-05-22 DE DE19742424950 patent/DE2424950A1/en active Pending
- 1974-05-22 IE IE1097/74A patent/IE39283B1/en unknown
- 1974-05-22 CA CA200,536A patent/CA977279A/en not_active Expired
- 1974-05-22 SE SE7406864A patent/SE402525C/en not_active IP Right Cessation
- 1974-05-22 IL IL44877A patent/IL44877A/en unknown
- 1974-05-22 NL NLAANVRAGE7406873,A patent/NL190436C/en not_active IP Right Cessation
- 1974-05-22 HU HUWE507A patent/HU170656B/hu unknown
- 1974-05-22 BE BE144636A patent/BE815409A/en not_active IP Right Cessation
- 1974-05-22 JP JP5776774A patent/JPS577128B2/ja not_active Expired
- 1974-05-22 FI FI1566/74A patent/FI156674A/fi unknown
- 1974-05-22 AT AT426774A patent/AT351167B/en not_active IP Right Cessation
- 1974-05-22 DK DK280174AA patent/DK144261C/en not_active IP Right Cessation
- 1974-05-22 FR FR7417820A patent/FR2230341B1/fr not_active Expired
- 1974-05-22 AU AU69252/74A patent/AU469472B2/en not_active Expired
- 1974-05-23 CY CY941A patent/CY941A/en unknown
- 1974-12-02 KE KE2808A patent/KE2808A/en unknown
-
1978
- 1978-01-05 HK HK13/78A patent/HK1378A/en unknown
- 1978-12-31 MY MY1978181A patent/MY7800181A/en unknown
-
1980
- 1980-06-13 IT IT8048966A patent/IT8048966A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL44877A (en) | 1976-11-30 |
FR2230341B1 (en) | 1977-04-15 |
JPS577128B2 (en) | 1982-02-09 |
FR2230341A1 (en) | 1974-12-20 |
JPS5040721A (en) | 1975-04-14 |
HK1378A (en) | 1978-01-13 |
KE2808A (en) | 1978-02-17 |
HU170656B (en) | 1977-07-28 |
BE815409A (en) | 1974-11-22 |
IL44877A0 (en) | 1974-07-31 |
ATA426774A (en) | 1978-12-15 |
ZA743318B (en) | 1975-05-28 |
IT8048966A0 (en) | 1980-06-13 |
GB1460302A (en) | 1977-01-06 |
DK144261C (en) | 1991-02-04 |
CA977279A (en) | 1975-11-04 |
IE39283L (en) | 1974-11-23 |
AT351167B (en) | 1979-07-10 |
NL190436B (en) | 1993-10-01 |
NL190436C (en) | 1994-03-01 |
NL7406873A (en) | 1974-11-26 |
AU6925274A (en) | 1975-11-27 |
CY941A (en) | 1978-06-23 |
DE2424950A1 (en) | 1974-12-19 |
SE402525B (en) | 1978-07-10 |
AU469472B2 (en) | 1976-02-12 |
SE402525C (en) | 1982-11-22 |
MY7800181A (en) | 1978-12-31 |
FI156674A (en) | 1974-11-24 |
DK144261B (en) | 1982-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES430431A1 (en) | Direct compression tabletting composition and pharmaceutical tablets produced therefrom | |
GB1405088A (en) | Slow release formulation | |
SG68683G (en) | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives,pharmaceutical compositions thereof,and process for their manufacture | |
DE3461054D1 (en) | Divisible tablet with sustained release of the active ingredient, and process for its production | |
DE3062114D1 (en) | Pyrimidine derivatives and their production and agricultural uses | |
GB1430684A (en) | Prolonged release lozenges | |
EP0213761A3 (en) | Stable sodium aspirin tablet compositions | |
AU7084587A (en) | Methylprednisolone/sodium carboxymethyl starch tablet composition | |
GB1227534A (en) | ||
IE39283B1 (en) | Tablet formulation | |
GB1464200A (en) | Pharmaceutical composition | |
JPS57152858A (en) | Acesulfam containing composition and production thereof | |
GB1191246A (en) | Vitamin-containing Preparations | |
CA930745A (en) | 9-azolylfluorene-9-carboxylic acid derivatives, a process for their production, and their use for the regulation of plant growth | |
GB1268146A (en) | Improvements in or relating to a contraceptive cervical obturator | |
FI46806B (en) | ||
AR248350A1 (en) | Aminoguanidine spray drying process. | |
CA922733A (en) | Process for the production of 1,1,3,3-tetramethyl guanidine | |
USD245865S (en) | Crushing plant | |
JPS542568A (en) | Crusher | |
AU2009970A (en) | Novel pharmaceutically active 4_acylamino-1,2,4-triazol derivatives and a process for their preperation | |
USD257682S (en) | Hobo doll | |
GB1287433A (en) | Pharmaceutical compositions | |
GB1445983A (en) | Pharmaceutical formulations | |
GB1498301A (en) | Processes and apparatus for producing active dried yeast |